GlassScriptPhysician profile
Larry H Chou
NPI 1841255643
$3,375.67
in general payments reported to CMS, 2019-2025
40 companies · $719 in 2025
The $719 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,679 · 2020: $408 · 2021: $124 · 2022: $192 · 2023: $143 · 2024: $112 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $350.59 | 2019-2022 | |
| Pacira Therapeutics, INC. | $347.60 | 2019-2021 | |
| Bioventus LLC | $309.86 | 2019-2025 | Xcell, Durolane |
| Collegium Pharmaceutical, INC. | $233.29 | 2019-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $186.35 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $176.48 | 2022-2025 | Gel-One Cross-Linked Hyaluronate |
| Zyla Life Sciences, INC. | $139.98 | 2019-2020 | |
| Abbott Laboratories | $131.77 | 2022-2025 | Octrode, Proclaim, Eterna |
| Depuy Synthes Sales INC. | $130.32 | 2019-2025 | Orthovisc, Monovisc |
| Nevro Corp. | $108.45 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $95.01 | 2025 | Euflexxa |
| Arbor Pharmaceuticals, INC. | $94.12 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $89.08 | 2021-2025 | Xeomin |
| Biodelivery Sciences International, INC. | $75.16 | 2019 | |
| Sanofi-Aventis U.S. LLC | $72.93 | 2019-2020 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.